Soleus Capital Management LP

-

Director Information, Funds, Firms

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Soleus Capital Management LP
FirmSoleus Capital Management LP
Address100 Field Point Road, Suite 200 Suite 200
Greenwich, CT 06830
Source
Associated Funds Form D Role 2011 - 2026 Raised AUM
Soleus Capital Management LP
SCOF SPV I LP 021-553372 Promoter
34.4 M 33.7 M
Soleus Credit Opportunities Fund I LP 021-518597 Promoter
144.2 M 155.1 M
Soleus Credit Opportunities Offshore Fund I LP 021-518598 Promoter
29.2 M
Soleus Private Equity Fund III LP 021-466549 Promoter
218.0 M
of 218.0 M
309.4 M
Soleus Private Equity Fund II LP 021-388464 Promoter
136.8 M
of 175.0 M
132.5 M
Soleus BA SPV LLC 021-340613 Executive Officer
8.3 M
of 8.3 M
0.1 M
Soleus BB SPV LLC 021-340613 Executive Officer
8.3 M
of 8.3 M
0.9 M
Soleus Capital Special Opportunities Fund LP 021-347654 Promoter
10.8 M 0.2 M
Soleus Capital Master Fund LP 021-321873 Promoter
583.9 M 3,016.2 M
Soleus Private Equity Fund I LP 021-321871 Promoter
85.5 M
of 125.0 M
6.6 M
Soleus BA SPV LLC 021-382158 Executive Officer
5.7 M
of 5.7 M
Soleus Capital Offshore Ltd 021-377368 Promoter
487.6 M
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Lyra Therapeutics Inc LYRA
Common Stock
2020-05-05 Sell 16,909 $16.00 270,544
Lyra Therapeutics Inc LYRA
Common Stock
2020-05-05 Buy 155,000 $16.00 2,480,000
Lyra Therapeutics Inc LYRA
Common Stock
2020-05-05 Conversion 338,330 $0.00
Lyra Therapeutics Inc LYRA
Common Stock
2020-05-05 Conversion 104,608 $0.00
Lyra Therapeutics Inc LYRA
Common Stock
2020-05-05 Option exercise 31,382 $8.63 270,827
Lyra Therapeutics Inc LYRA
Series B Convertible Preferred Stock · derivative
2020-05-05 Conversion 11,666,666 $0.00
Lyra Therapeutics Inc LYRA
Common Stock Warrant · derivative
2020-05-05 Option exercise 31,382 $0.00
Lyra Therapeutics Inc LYRA
Series C Convertible Preferred Stock · derivative
2020-05-05 Conversion 3,607,224 $0.00
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com